PharmacoEconomics

Lifestyle Drugs: Determining Their Value and Who Should Pay
pp. 441-448(8)
Author: Mitrany D.

Hip Fracture Prevention: Cost-Effective Strategies
pp. 449-468(20)
Authors: Vestergaard P.; Rejnmark L.; Mosekilde L.

Cost Considerations in the Use of Anaesthetic Drugs
pp. 469-481(13)
Author: Smith I.

The Lifetime Cost of Bipolar Disorder in the US: An Estimate for New Cases in 1998
pp. 483-495(13)
Authors: Begley C.E.; Annegers J.F.; Swann A.C.; Lewis C.; Coan S.; Schnapp W.B.; Bryant-Comstock L.

Cost Effectiveness of Ramipril in Patients with Non-Diabetic Nephropathy and Hypertension: Economic Evaluation of Ramipril Efficacy In Nephropathy (REIN) Study for Germany from the Perspective of Statutory Health Insurance
pp. 497-512(16)
Authors: Schädlich P.K.; Brecht J.G.; Brunetti M.; Pagano E.; Rangoonwala B.; Huppertz E.

The Cost of Inadequate Prescriptions for Hypolipidaemic Drugs
pp. 513-522(10)
Authors: Ballesteros L.C.; San Martin M.I.F.; Cuesta T.S.; Mayor E.E.; Bilbao C.L.

Cost Effectiveness of Selective Decontamination of the Digestive Tract in Liver Transplant Patients
pp. 523-530(8)
Authors: van Enckevort P.J.; Zwaveling J.H.; Bottema J.T.; Maring J.K.; Klompmaker I.J.; Slooff M.J.H.; Ten Vergert E.M.

Economic Evaluation of Systemic Treatments for Cytomegalovirus Retinitis in Patients with AIDS
pp. 535-550(16)
Authors: Lee T.A.; Sullivan S.D.; Veenstra D.L.; Ramsey S.D.; Steger P.J.K.; Malinverni R.; Pleil A.M.; Williamson T.

Economic Evaluation of a New Acellular Vaccine for Pertussis in Canada
pp. 551-563(13)
Authors: Iskedjian M.; Einarson T.R.; O'Brien B.J.; De Serres J.G.; Gold R.; Gemmill I.M.; Milkovich N.; Rosner A.

Cost Effectiveness of Nasal Calcitonin in Postmenopausal Women: Use of Cochrane Collaboration Methods for Meta-Analysis Within Economic Evaluation
pp. 565-575(11)
Authors: Coyle D.; Cranney A.; Lee K.M.; Welch V.; Tugwell P.

Gastrointestinal-Related Healthcare Resource Usage Associated with a Fixed Combination of Diclofenac and Misoprostol versus Other NSAIDs
pp. 577-588(12)
Authors: Rahme E.; Joseph L.; Kong S.X.; Watson D.J.; Pellissier J.M.; LeLorier J.

Cost Effectiveness of Desirudin Compared with a Low Molecular Weight Heparin in the Prevention of Deep Vein Thrombosis after Total Hip Replacement Surgery
pp. 589-597(9)
Authors: Levin L-Å.; Bergqvist D.

The Cost Effectiveness of Tapered versus Abrupt Discontinuation of Oral Cyclosporin Microemulsion for the Treatment of Psoriasis
pp. 599-608(10)
Authors: Hakkaart-van Roijen L.; Verboom P.; Redekop W.K.; Touw K.R.; Rutten F.F.H.